Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookStandard Treatment Guidelines (STG) and The National Essential Drug List for Tanzania (NEDLIT) (WHO; 1997; 210 pages)
View the documentFOREWORD
View the documentACKNOWLEDGMENTS
View the documentINTRODUCTION
close this folderStandard Treatment Guidelines (STG)
Open this folder and view contents1. GASTROINTESTINAL CONDITIONS
Open this folder and view contents2. RESPIRATORY DISEASES
Open this folder and view contents3. OBSTETRIC AND GYNAECOLOGICAL CONDITIONS AND CONTRACEPTION
close this folder4. CARDIOVASCULAR DISEASES
Open this folder and view contents4.1 Infections
Open this folder and view contents4.2 Rheumatic Heart Disease
View the document4.3 Treatment of Acute Arthritis and Carditis
Open this folder and view contents4.4 Hypertension
close this folder4.5 Cardiac failure
View the document4.5.1 Mild to Moderate and Severe Cardiac Failure
View the document4.5.2 Acute Pulmonary Oedema
View the document4.5.3 Resistant cardiac failure
Open this folder and view contents4.6 Angina Pectoris
Open this folder and view contents4.7 Myocardial Infarction (Ml)
Open this folder and view contents5. MALARIA
Open this folder and view contents6. SKIN DISEASES
Open this folder and view contents7. SEXUALLY TRANSMITTED INFECTIONS / DISEASES (STD)
Open this folder and view contents8. DENTAL AND ORAL CONDITIONS
Open this folder and view contents9. GENITO-URINARY DISEASES: KIDNEY CONDITIONS
Open this folder and view contents10. EAR, NOSE AND THROAT CONDITIONS
Open this folder and view contents11. EYE CONDITIONS
Open this folder and view contents12. TUBERCULOSIS AND LEPROSY
Open this folder and view contents13. MUSCULOSKELETAL CONDITIONS AND JOINT DISEASES
Open this folder and view contents14. METABOLIC AND ENDOCRINE SYSTEM CONDITIONS
Open this folder and view contents15. CENTRAL NERVOUS SYSTEM DISEASE CONDITIONS
Open this folder and view contents16. OTHER DISEASE CONDITIONS
Open this folder and view contents17. VIRAL INFECTIONS
Open this folder and view contents18. ALLERGIC REACTIONS
Open this folder and view contents19. NUTRITIONAL AND HAEMATOLOGIC CONDITIONS
Open this folder and view contents20. MALIGNANT DISEASE CONDITIONS
Open this folder and view contents21. INJURIES AND TRAUMA
View the document22. FOREIGN BODIES
View the document23. PAIN
View the document24. POISONING
View the document25. NORMAL LABORATORY VALUES
Open this folder and view contentsNATIONAL ESSENTIAL DRUG LIST
View the documentABBREVIATIONS AND SYMBOLS
 
4.5.3 Resistant cardiac failure

Stop the thiazide diuretic, and commence:

Frusemide (O) 40-200 mg once daily in the morning

Plus


Potassium chloride (O) 600 mg once daily, for each 40 mg Frusemide given.


If still unsatisfactory, stop Potassium supplement and add a Potassium-sparing diuretic:

Spironoloctone (O) 5-20 mg once daily.

Monitor potassium levels.


If still unsatisfactory add a vasodilator to reduce cardiac afterload:

Hydralazine (O) initial dose 25 mg twice daily; increasing to 50 mg two to three times a day Monitor BP regularly.


If still unsatisfactory consider referral

Further management under specialist care:

Captopril (O) initially 6.25 mg once daily gradually increasing to 25 mg three times a day. The first dose should be followed by careful BP monitoring.


CAUTION Potassium supplements to be stopped and levels monitored regularly.

Use and Indications for Digoxin

Digoxin toxicity is a very common problem especially in the elderly and paediatric age groups. Although digoxin may be tried in patients in sinus rhythm its continued use when heart failure under control is to be discouraged.

Digoxin is indicated in:

• children in heart failure
• tachycardia of greater than 100/beats/minute
• fast atrial fibrillation or flutter


To digitalise (check serum potassium levels before starting)

Adults

Digoxin (O)
average dose 500 micrograms stat followed by 125-250 micrograms once daily

Children

10 micrograms/kg/24 hrs (once daily); However when starting treatment give this dose three times in the first 24 hours then continue with one dose daily.

to previous sectionto next section

Please provide your feedback
Abbreviations
English  |  French